# High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic Hyperplasia

> **NCT07572097** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 288 (estimated)

## Conditions studied

- BPH

## Interventions

- **PROCEDURE:** H-FIRE
- **PROCEDURE:** Surgical Standard of Care (TURP or HoLEP)

## Key facts

- **NCT ID:** NCT07572097
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-05
- **Primary completion:** 2028-05-05
- **Final completion:** 2029-05-05
- **Target enrollment:** 288 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07572097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07572097, "High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07572097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*